IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD USING AN INTERLEUKIN-2 RECEPTOR ALPHA, BETA-SELECTIVE AGONIST IN COMBINATION WITH ADOPTIVE CELL TRANSFER THERAPY
Nektar Therapeutics;The Regents of the University of California
发明人:
Deborah H. Charych,Antoni Ribas,Giulia Parisi
申请号：
US16490443
公开号：
US20200016206A1
申请日:
2018.03.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided are methods and compositions directed towards the treatment of an individual having cancer by providing adoptive cell transfer therapy and administering to the individual a long acting IL-2Rαβ-biased agonist.
